In a large, multicentre study of multiple measures, Thompson and Gray et al. demonstrate plasma neurofilament light chain as the leading prognostic biomarker in amyotrophic lateral sclerosis. The gene discussed is NEFL; the disease is amyotrophic lateral sclerosis.